An epigenetic signature in peripheral blood predicts active ovarian cancer
about
A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissueThe complexity of epigenetic diseasesReview of processing and analysis methods for DNA methylation array dataDNA methylation changes in epithelial ovarian cancer histotypes.Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association studyMosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorderPeripheral blood immune cell methylation profiles are associated with nonhematopoietic cancersLeukocyte-adjusted epigenome-wide association studies of blood from solid tumor patientsCorrelation of an epigenetic mitotic clock with cancer riskEstimation of blood cellular heterogeneity in newborns and children for epigenome-wide association studiesAberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancerNon-CG DNA methylation is a biomarker for assessing endodermal differentiation capacity in pluripotent stem cellsAn integrative network algorithm identifies age-associated differential methylation interactome hotspots targeting stem-cell differentiation pathwaysDifferential DNA methylation of MSI2 and its correlation with diabetic traits.DNA methylation arrays as surrogate measures of cell mixture distribution.Comments on: Interpretation of genome-wide infinium methylation data from ligated DNA in formalin-fixed paraffin-embedded paired tumor and normal tissueCell-composition effects in the analysis of DNA methylation array data: a mathematical perspective.Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitusAccounting for cellular heterogeneity is critical in epigenome-wide association studies.Pyrosequencing Evaluation of Widely Available Bisulfite Conversion Methods: Considerations for Application.Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.Methylation patterns in whole blood correlate with symptoms in schizophrenia patients.Single-cell entropy for accurate estimation of differentiation potency from a cell's transcriptomeEffects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets.DNA methylation profiles in ovarian cancer: implication in diagnosis and therapy (Review)Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.Maternal genome-wide DNA methylation patterns and congenital heart defects.Parental ages and levels of DNA methylation in the newborn are correlated.Tobacco-smoking-related differential DNA methylation: 27K discovery and replicationStatistical approaches for the analysis of DNA methylation microarray dataA beta-mixture model for dimensionality reduction, sample classification and analysis.Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome.A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival.Modulation of age- and cancer-associated DNA methylation change in the healthy colon by aspirin and lifestyle.Similar blood-borne DNA methylation alterations in cancer and inflammatory diseases determined by subpopulation shifts in peripheral leukocytes.IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation dataIdentification of driver and passenger DNA methylation in cancer by epigenomic analysis.A comparison of feature selection and classification methods in DNA methylation studies using the Illumina Infinium platform.The application of massively parallel sequencing technologies in diagnostics.Immortalization of T-cells is accompanied by gradual changes in CpG methylation resulting in a profile resembling a subset of T-cell leukemias.
P2860
Q21563356-83C68B8B-ECE3-4762-8D4A-87F8412224C8Q26784416-87F1DE00-A2E9-4962-B3DF-17712C8025B3Q27027775-012FB575-2CAE-480F-98EB-23871A052804Q27690722-EE920414-EF4E-4A3A-85CB-B6665D6CC9A2Q28383789-CAC4098E-FB56-4D52-89DF-1811035028F4Q28386912-D74A6059-4302-4132-833B-7FBEBABDEAE3Q28387330-F8860067-250A-46AB-BFD0-777CA92A85DFQ28388342-45ABDD13-9BFD-4717-8E6B-519B8CAAFA01Q28390569-A9AA5629-41F9-48BE-B81F-D70D74F8AB7AQ28393392-94A5946E-16A9-4B6F-8444-1BAE8E2F47CCQ28543351-89F2854E-B7A0-4F99-9A78-DBC3CA77B9CBQ28601391-17353345-93B6-4A19-8EED-184712C03DA8Q28709213-52A2131B-B6A9-4087-B282-2CD47A99E485Q30354797-5BA199AB-F37A-432A-8D0A-8797CB9E2A0EQ30530775-CB258810-85DB-4C9E-8A83-958AEC613B83Q30577331-6CC9CA54-8FC0-4407-8D10-960D282D5986Q30935846-2D9EB5DB-FAA1-4542-9C8A-431B903D5282Q33650362-3BF938D0-FA6E-4B72-A060-C949A1B346A3Q33742004-4C249237-61CA-4DCB-A523-162DDD6E7D1FQ33758127-C745044B-7E0B-4CBD-9111-0E65F95FD683Q33762434-8C63ED42-4ABE-4DB5-A980-AC37411DA70EQ33762454-A1E01A9F-B1D3-4690-8E03-8576826020E6Q33771221-E62B66D1-73F0-499D-A5E5-A54A9641A2CEQ33787509-C019F8A8-C322-4548-862D-0EDD21774C05Q33799002-AB72CA0C-9381-4A7E-AB3B-2F9407EA8061Q33810288-A0853C4C-8590-4BC5-BE46-C6D8669D4396Q33812860-7555909E-97A9-4AC4-8917-073A0443C679Q33858944-455CF5F3-39BC-4BC7-BE4F-2170B4E0FBB1Q33860650-98317608-F44F-43CC-8D69-CD942412ADF3Q33881906-184A28B0-AA2D-469C-A135-2C285F7F3B4DQ33914431-F121D79D-8BBE-4B61-90FE-27836C8839E8Q33915396-868422D2-09A6-44BD-A120-10DF404C71BFQ33948754-1365CA03-5A48-4909-9D23-D5339F44695EQ33958348-98B49B43-7499-4577-B8F3-0FFF00C2D135Q33994413-889E5143-490E-4682-A89E-99C06EAB64AFQ34130053-7B642C2A-701D-44D0-84C1-FC5DCA66C5AFQ34181789-31FBC22B-AF46-4562-B957-7589F9BBC163Q34242041-3E624CF6-5E78-4193-B076-66A78FBE41EFQ34344260-DB6ED67A-5CB8-4B75-AC4E-6DFCC472638DQ34347248-2BD36F11-9345-4A10-944E-0D5B4943B0E7
P2860
An epigenetic signature in peripheral blood predicts active ovarian cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
An epigenetic signature in peripheral blood predicts active ovarian cancer
@ast
An epigenetic signature in peripheral blood predicts active ovarian cancer
@en
An epigenetic signature in peripheral blood predicts active ovarian cancer.
@nl
type
label
An epigenetic signature in peripheral blood predicts active ovarian cancer
@ast
An epigenetic signature in peripheral blood predicts active ovarian cancer
@en
An epigenetic signature in peripheral blood predicts active ovarian cancer.
@nl
prefLabel
An epigenetic signature in peripheral blood predicts active ovarian cancer
@ast
An epigenetic signature in peripheral blood predicts active ovarian cancer
@en
An epigenetic signature in peripheral blood predicts active ovarian cancer.
@nl
P2093
P2860
P50
P1433
P1476
An epigenetic signature in peripheral blood predicts active ovarian cancer
@en
P2093
Allison Jones
Andrew E Teschendorff
Ian J Jacobs
Martin Widschwendter
Matthias Lechner
Simon A Gayther
Sophia Apostolidou
Stephan Beck
P2860
P356
10.1371/JOURNAL.PONE.0008274
P407
P577
2009-12-18T00:00:00Z